deciphering fibrosis: drivers of fibrotic disease in the liver and heart
Published 4 years ago • 10K plays • Length 1:01:38Download video MP4
Download video MP3
Similar videos
-
54:09
the dawn of translation in nash and hepatic fibrosis
-
52:54
regulation of cardiac fibrosis: insights from cell therapy
-
52:22
cardiovascular disease in nafld: identifying and managing cv risk
-
25:39
the liver-heart axis – does nash drive cardiovascular disease? - sven francque, md, phd
-
1:39:36
webinar | fibrosis as a driver of cancer, liver, and heart-related outcomes
-
1:40
immunology advance: how an immune molecule initiates liver fibrosis
-
57:06
the liver in cardiac disease
-
1:24:10
cardiovascular research discoveries -june 2022 -nikolaos frangogiannis, alex pinto, ryszard nosalski
-
34:24
liver fibrosis | nash and nafld | the balance between formation and degradation in the ecm
-
1:41
rgs4 promotes cardiac fibrosis in mice with heart attack
-
49:20
jca w7 - dr. nikolaos frangogiannis - cardiac fibrosis
-
57:27
machine intelligence in cardiac imaging
-
57:46
webinar: easl update - fibroscan applications in nafld-nash
-
38:23
deciphering liver values
-
1:33
how hepatitis b virus activates hepatic stellate cells to drive liver fibrosis.mp4
-
1:03:48
demystifying pulmonary fibrosis with single cell rna sequencing
-
19:54
transient elastography: beyond diagnosis of fibrosis
-
1:07:11
regression of fibrosis in chronic liver disease - dr. theise (nyu) #liverpath
-
28:21
kidney fibrosis | turnover of the interstitial ecm as a predictor of adverse outcomes